AEON Biopharma (AEON) vs Marker Therapeutics (MRKR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Marker Therapeutics (MRKR) has outperformed AEON Biopharma (AEON) over the past year, losing 1.9% versus a loss of 66.7%. Marker Therapeutics is the larger company by market cap ($15.8 million vs $15.5 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AEON | MRKR |
|---|---|---|
| Share price | $0.31 | $0.95 |
| Market cap | $15.46M | $15.84M |
| 1-day change | -0.40% | -8.65% |
| YTD return | -71.70% | -30.20% |
| 1-year return | -66.71% | -1.89% |
| 5-year return | — | -93.46% |
| EPS (TTM) | $-4.39 | $-0.42 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.45 | $2.46 |
| 52-week low | $0.177 | $0.84 |
| Distance from 52-week high | -78.62% | -61.38% |
| Average volume | 8.58M | 64.80K |
| Shares outstanding | 49.88M | 16.67M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- MRKR has outperformed AEON by 64.8 percentage points over the past year.
AEON vs MRKR FAQ
Which is bigger, AEON Biopharma or Marker Therapeutics?
Marker Therapeutics (MRKR) is larger, with a market capitalization of $15.84M compared with $15.46M for AEON Biopharma (AEON).
Which stock has performed better over the past year, AEON or MRKR?
MRKR returned -1.89% over the past 12 months, compared with -66.71% for AEON (price return, excluding dividends). Past performance does not predict future results.
Are AEON Biopharma and Marker Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.